{"url_path":"/sec/ivf/10-q/2026/item-6","section_key":"item-6","section_title":"Item 6 Exhibits**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1417926/0001493152-26-029514-index.html","accession_number":"0001493152-26-029514","cik":"0001417926","ticker":"IVF","issuer_name":"INVO Fertility, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1417926/0001493152-26-029514-index.html","primary_entity_key":"0001417926","primary_entity_name":"INVO Fertility, Inc."},"word_count":250,"has_tables":true,"body_markdown":"** **\n\n**Item\n6. Exhibits**\n\n \n\nExhibit No.\n \nDescription\n\n \n \n \n\n31.1*\n \n[Certification\nof Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant\nto Section 302 of the Sarbanes-Oxley Act of 2002](ex31-1.htm)\n\n \n \n \n\n31.2*\n \n[Certification\nof Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant\nto Section 302 of the Sarbanes-Oxley Act of 2002](ex31-2.htm)\n\n \n \n \n\n32.1**\n \n[Certification\nof Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section\n906 of the Sarbanes-Oxley Act of 2002](ex32-1.htm)\n\n \n \n \n\n101.INS*\n \nInline\nXBRL Instance Document\n\n \n \n \n\n101.SCH*\n \nInline\nXBRL Taxonomy Extension Schema Document\n\n \n \n \n\n101.CAL*\n \nInline\nXBRL Taxonomy Extension Calculation Linkbase Document\n\n \n \n \n\n101.DEF*\n \nInline\nXBRL Taxonomy Extension Definition Linkbase Document\n\n \n \n \n\n101.LAB*\n \nInline\nXBRL Taxonomy Extension Label Linkbase Document\n\n \n \n \n\n101.PRE*\n \nInline\nXBRL Taxonomy Extension Presentation Linkbase Document\n\n \n \n \n\n104*\n \nCover\nPage Interactive Data File - the cover page from the Registrant’s Quarterly Report on Form 10-Q for the quarter ended March\n31, 2026 is formatted in Inline XBRL\n\n \n \n \n\n \n \n*\nFiled herewith.\n\n \n \n**\nFurnished herewith.\n\n \n\n40\n\n \n\n** **\n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its\nbehalf by the undersigned, thereunto duly authorized on June 22, 2026.\n\n \n\n \n**INVO\nFertility, Inc.**\n\n \n \n \n\nDate:\nJune 22, 2026\nBy:\n\n*/s/\nSteven Shum*\n\n \n \n**Steven\nShum, Chief Executive Officer**\n\n \n \n(Principal\nExecutive Officer)\n\n \n\nDate:\nJune 22, 2026\nBy:\n*/s/\nTerah Krigsvold*\n\n \n \n**Terah\nKrigsvold, Chief Financial Officer**\n\n \n \n(Principal\nFinancial and Accounting Officer)\n\n \n\n41\n\n** **"}